These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 35049602)

  • 1. SATB2 and MDM2 Immunoexpression and Diagnostic Role in Primary Osteosarcomas of the Jaw.
    Owosho AA; Ladeji AM; Adesina OM; Adebiyi KE; Olajide MA; Okunade T; Palmer J; Kehinde T; Vos JA; Cole G; Summersgill KF
    Dent J (Basel); 2021 Dec; 10(1):. PubMed ID: 35049602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MDM2 and CDK4 immunohistochemistry is a valuable tool in the differential diagnosis of low-grade osteosarcomas and other primary fibro-osseous lesions of the bone.
    Dujardin F; Binh MB; Bouvier C; Gomez-Brouchet A; Larousserie F; Muret Ad; Louis-Brennetot C; Aurias A; Coindre JM; Guillou L; Pedeutour F; Duval H; Collin C; de Pinieux G
    Mod Pathol; 2011 May; 24(5):624-37. PubMed ID: 21336260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of MDM2, CDK4, BCL2, Parafibromin and Galectin 1 in Differentiating Osteosarcoma from its Benign Fibro-osseous Lesions.
    Kaur H; Kala S; Sood A; Mridha AR; Kakkar A; Yadav R; Mishra S; Mishra D
    Head Neck Pathol; 2022 Sep; 16(3):728-737. PubMed ID: 35220546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Utility of MDM2 and CDK4 Immunohistochemistry and MDM2 FISH in Craniofacial Osteosarcoma.
    Limbach AL; Lingen MW; McElherne J; Mashek H; Fitzpatrick C; Hyjek E; Mostofi R; Cipriani NA
    Head Neck Pathol; 2020 Dec; 14(4):889-898. PubMed ID: 32026294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of radiological and clinicopathological features of craniofacial fibro-osseous lesions].
    Yang XD; Xu G; Song LH; Zhu H; Liu X; Li FH; Peng SK; Ma ZY; Zhou H
    Zhonghua Bing Li Xue Za Zhi; 2020 Feb; 49(2):122-128. PubMed ID: 32074723
    [No Abstract]   [Full Text] [Related]  

  • 6. [Value of MDM2, CDK4 and SATB2 immunohistochemistry in histologic diagnosis of low-grade osteosarcoma].
    Chen CY; Zhang HZ; Jiang ZM; Zhou J; Chen J; Liu L
    Zhonghua Bing Li Xue Za Zhi; 2016 Jun; 45(6):387-92. PubMed ID: 27256046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new subtype of high-grade mandibular osteosarcoma with RASAL1/MDM2 amplification.
    Guérin M; Thariat J; Ouali M; Bouvier C; Decouvelaere AV; Cassagnau E; Aubert S; Lepreux S; Coindre JM; Valmary-Degano S; Larousserie F; Meilleroux J; Projetti F; Stock N; Galant C; Marie B; Peyrottes I; de Pinieux G; Gomez-Brouchet A
    Hum Pathol; 2016 Apr; 50():70-8. PubMed ID: 26997440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The utility of SATB2 immunohistochemical expression in distinguishing between osteosarcomas and their malignant bone tumor mimickers, such as Ewing sarcomas and chondrosarcomas.
    Machado I; Navarro S; Picci P; Llombart-Bosch A
    Pathol Res Pract; 2016 Sep; 212(9):811-6. PubMed ID: 27465835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosome 12 long arm rearrangement covering MDM2 and RASAL1 is associated with aggressive craniofacial juvenile ossifying fibroma and extracranial psammomatoid fibro-osseous lesions.
    Tabareau-Delalande F; Collin C; Gomez-Brouchet A; Bouvier C; Decouvelaere AV; de Muret A; Pagès JC; de Pinieux G
    Mod Pathol; 2015 Jan; 28(1):48-56. PubMed ID: 24925056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Detection of MDM2 gene amplification by fluorescence in situ hybridization and its diagnostic value in low-grade osteosarcoma].
    Li L; Zhang M; Dong RF; Su YB; Ding Y
    Zhonghua Bing Li Xue Za Zhi; 2024 Mar; 53(3):237-242. PubMed ID: 38433050
    [No Abstract]   [Full Text] [Related]  

  • 11. MDM2 Gene Amplification and Expression of MDM2 and CDK4 are Rare in Ossifying Fibroma of Craniofacial Bones.
    Bahceci DH; Jordan RCK; Horvai AE
    Head Neck Pathol; 2022 Dec; 16(4):991-997. PubMed ID: 35546651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SATB2 is not a reliable diagnostic marker for distinguishing between oral osteosarcoma and fibro-osseous lesions of the jaws.
    Grad-Akrish S; Rachmiel A; Ben-Izhak O
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2021 May; 131(5):572-581. PubMed ID: 33309262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical and diagnostic imaging findings of osteosarcoma of the jaw.
    Nakayama E; Sugiura K; Ishibashi H; Oobu K; Kobayashi I; Yoshiura K
    Dentomaxillofac Radiol; 2005 May; 34(3):182-8. PubMed ID: 15897290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MDM2 and CDK4 immunohistochemical coexpression in high-grade osteosarcoma: correlation with a dedifferentiated subtype.
    Yoshida A; Ushiku T; Motoi T; Beppu Y; Fukayama M; Tsuda H; Shibata T
    Am J Surg Pathol; 2012 Mar; 36(3):423-31. PubMed ID: 22301501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical analysis of MDM2 and CDK4 distinguishes low-grade osteosarcoma from benign mimics.
    Yoshida A; Ushiku T; Motoi T; Shibata T; Beppu Y; Fukayama M; Tsuda H
    Mod Pathol; 2010 Sep; 23(9):1279-88. PubMed ID: 20601938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amplification and protein expression of chromosome 12q13-15 genes in osteosarcomas of the jaws.
    Lopes MA; Nikitakis NG; Ord RA; Sauk J
    Oral Oncol; 2001 Oct; 37(7):566-71. PubMed ID: 11564577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic value of MDM2 RNA in situ hybridization for low-grade osteosarcoma: Consistency comparison of RNA in situ hybridization, fluorescence in situ hybridization, and immunohistochemistry.
    Chen C; He X; Chen M; Du T; Qin W; Jing W; Zhang H
    Virchows Arch; 2023 Jun; 482(6):999-1010. PubMed ID: 36977943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psammomatoid Ossifying Fibroma Is Defined by SATB2 Rearrangement.
    Cleven AHG; Szuhai K; van IJzendoorn DGP; Groen E; Baelde H; Schreuder WH; Briaire-de Bruijn IH; van der Meeren SW; Kleijwegt MC; Furth WR; Kroon HM; Suurmeijer AJH; Savci-Heijink DC; Baumhoer D; Bovée JVMG
    Mod Pathol; 2023 Jan; 36(1):100013. PubMed ID: 36788065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Significance of SATB2 in the pathologic diagnosis of osteosarcoma].
    Li M; Cai YP; Lu KY; Chen Y; Zhu X; Yin Y; Tang J
    Zhonghua Bing Li Xue Za Zhi; 2016 Sep; 45(9):631-5. PubMed ID: 27646893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SATB2 is frequently expressed in ossifying and non-ossifying peripheral oral fibroma of the gingival region but not in reactive fibromatous lesions from other intraoral sites.
    Baněčková M; Agaimy A
    Ann Diagn Pathol; 2020 Jun; 46():151510. PubMed ID: 32252013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.